chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: HEP
Symptoms: Pain
Clinical narrative: 5/27/02 Felt pain Left side of head down to shoulder and upper back to point of waking from sleep. Pain on and off since 5/27. Relieved with APAP, ibuprofen and Alleve.
Age: 1.5
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: This report describes a swollen thigh in an 18 month old male who received an injection of DTaP. There were no concomitant medical conditions or medications. There was no illness at the time of immunization. The child had a history of rash following amoxicillin. He had no adverse experience following receipt of previous immunizations. The child received his fourth injection of DTaP at 15:00 hours on 01/15/01. That day, he also received his third injection of inactivated poliomyelitis virus vaccine. By the next morning, the child had developed redness, warmth and swelling at the site of DTaP administration. The injection site swelling extended from hip to knee and was "almost circumferential". The child recovered.
Age: 1.25
Sex: F
Vaccine: DTAP, PNC
Symptoms: Decreased appetite, Nasal congestion, Pyrexia, Somnolence
Clinical narrative: On 01/12/2001 14:00, the vaccinee received the unspecified dose of DTaP and the first IM dose of Prevnar. Three to four hrs post-vaccination, the vaccinee experienced a fever decreased appetite, drowsiness, and nasal congestion. It was noted that the nasal congestion was persisting one wk later As of03/30/01,the outcome of the events was unknown.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Diarrhoea, Haematochezia, Nasal congestion, Pyrexia, Sleep disorder
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Vomiting
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Diarrhoea, Faeces pale, Haematochezia, Nasal congestion, Pyrexia
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Somnolence, Vomiting
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Diarrhoea, Haematochezia, Laboratory test abnormal, Nasal congestion, Pyrexia
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, MEN, PNC
Symptoms: Abnormal faeces, Pyrexia, Rhinitis, Somnolence, Vomiting
Clinical narrative: Report 20010091431 described bloody stool in a two month old male who received Infanrix. Allergies, medical history and illness at the time of vaccinations were unknown. It was unknown whether the vaccinee had illness at the time of vaccination. On 02/16/2001, the vaccinee received his first IM left thigh dose of Infanrix, his first IM right thigh dose of Prevnar, his first IM left thigh dose of Pedvax-HIB, his first SC left arm dose of IPV, and his second IM right thigh dose of Engerix B. On 02/17/2001, the child developed congestion (NOS), a slight fever, vomited one time and was sleeping "a lot." The child was seen by a local pediatrician and was noted to have clear lungs, soft abdomen, a soft stool with some mucous and blood. he child's mother was advised to stop drinking milk. On 02/18/201, the child was noted to have a yellow stool; additional physical findings were normal. On 02/22/2001, the child's pediatrician noted "mucoid stools and blood noted. Child acts fine. 6-7 stools/day with blod, appear not as green." The child's mother received "Keflex two weeks ago for mastitis." On 05/01/200 the vaccinee's pediatrician stated that the vaccinee "continues to have diarrhea with mucous and further blood." Further evaluation was pending with a ediatric gastrointestinal physician. No drugs were used to treat the adverse events. The reporter stated that the adverse events were moderate in intensity. As of 09/05/2001, the events had resolved.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Cellulitis, Injection site erythema, Injection site oedema
Clinical narrative: This report describes erythema and swelling at the injection site of a 4 year old female who receivede DTaP. No concomitant vaccinations at the time of the DTaP administation. She had no known adverse experiences following receipt of previous immunizations. On 05/29/01, the child received an injection of DTaP; she had received previous injections of DTaP but the number of previous injections was not provided. The next day, on 05/30/01, she developed erythema and swelling at the DTaP injection site. The vaccine extended an unspecified distance from the injection site. The swelling extended an unspecified distance from the injection site The vaccine provider stated "It was unclear as to whether or not the child had an allergic reaction of cellulitis developed after injection". The child was treated with one 500-mg intramuscular injection of ceftriaxone (Rocephin), and oral amoxicillin/clavulanate (Augmentin) 400 mg twice daily for ten days. The reactions resolved by 06/01/01, when the child was re-examined by the vaccine provider. The vaccine provider considered the redness and swelling at the injection site to be moderate in intensity and possibly related to DTaP administrartion. The vaccine provider indicated that the events could be associated with "cellulitis secondary to puncture wound of DTaP administration.
Age: 0.25
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia, Respiratory disorder, Upper respiratory tract infection, Wheezing
Clinical narrative: On 1/24/01 15:30, the vaccinee received the 1st IM RL dose of Infanrix, the 1st IM RL dose of 7-valent pneumococcal conjugate vaccine (Prevnar), the 1st IM RL dose of Haemophilus influenzae type B conjugate (Pedivax-Hib) and the 1st IM LL dose of IM polio vaccine (IPOL). The physician reported that immediately after vaccination, the vaccinee developed respiratory difficulty NOS and wheezing. On 3/19/01, when the vaccinee was 5 months old, the vaccinee's mother reported to the pediatrician that the infant developed "respiratory difficulty", wheezing, and oral thrush. As of 7/30/01, the outcome of the events was unknown.
Age: 0.25
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, DTAP, HIBV, IPV, PNC
Symptoms: Candidiasis, Respiratory disorder, Wheezing
Clinical narrative: On 1/24/01 15:30, the vaccinee received the 1st IM RL dose of Infanrix, the 1st IM RL dose of 7-valent pneumococcal conjugate vaccine (Prevnar), the 1st IM RL dose of Haemophilus influenzae type B conjugate (Pedivax-Hib) and the 1st IM LL dose of IM polio vaccine (IPOL). The physician reported that immediately after vaccination, the vaccinee developed respiratory difficulty NOS and wheezing. On 3/19/01, when the vaccinee was 5 months old, the vaccinee's mother reported to the pediatrician that the infant developed "respiratory difficulty", wheezing, and oral thrush. As of 7/30/01, the outcome of the events was unknown.
Age: 1.7
Sex: F
Vaccine: DTAP
Symptoms: Convulsion, Pyrexia
Clinical narrative: The child had no concurrent conditions or significant medical history. She was taking no concurrent medications. She received her 4th injection of Infanrix on 8/15/01. "Soon after getting home" from the physician's office, the child developed a fever of 104F. She was taken to the ER. CBC and UA were performed; results were not provided. The fever was treated with acetaminophen (Tylenol) and ibuprofen (Motrin). While in the ER, the child experienced a "15-minute general seizure"; the seizure was treated with rectal diazepam (Valium). The child was sent home from the ER. The child's mother reported that the child experienced a "one-second seizure" on the morning of 8/16/01. The most recent information was received on 11/27/01. The fever resolved on 8/16/01. The seizures resolved on an unspecified date. The reporter considered the fever to be severe in intensity and related to Infanrix administration. The reporter considered the seizures to be moderate in intensity and related to Infanrix administration. The Infanrix immunization series was discontinued. The seizures are considered "Medially Serious".
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying, Cyanosis
Clinical narrative: Report 2001021044-1 describes cyanosis of the legs of a 2 month old female who received an injection of Infanrix. Medical history, concurrent conditions and concurrent medications were not specified. There was no known illness at the time of immunization. On 08/28/2001, the infant received her first injection of Infanrix. On the same day, she also received her first injections of Prevnar, IPOL and Act-Hib. Later that day, an unspecified time post-immunization, the infant experienced cyanosis of her legs and she screamed. The infant was seen by the reporter. The cyanosis resolved after 10 mins, without treatment. The screaming resolved after an unspecified period of time. The reporter indicated that the vaccine provider did not consider the events to be related to immunization. The reporter considered the cyanosis of the legs to be mild in intensity and possibly related to all the vaccines administered. The infant received her second injection of Infanrix at 4 months of age. No adverse events were reported following the second injection of Infanrix. Specifically, the reporter indicated that the cyanosis of the legs and screaming did not recur.
Age: 0.19
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Crying, Erythema, Opisthotonus, Salivary hypersecretion
Clinical narrative: This report describes a seizure in a 2 month old male who received an injection of Infanrix. On 09/04/2001, the infant received his first injection of Infanrix. On that date, he also received injection of Comvax, IPOL and Prevnar. On 09/05/01, approximately 27 hours post-immunization, the infant woke from his nap crying. His mother observed that he arched his back, thrust his head back and turned red. His tongue was blue and he was foaming at the mouth. The mother also described the infant as having a momentary blank stares. All these events lasted approximately five minutes after the infant woke from his nap. She stated that the baby appeared "OK" at the time but was a little bit out of it". She immediately brought the baby to the doctor's office. By 15;30, the baby appeared to be sleepy, but the mother noted that this was a usual "sleepy time" for the baby. The doctor admitted the baby to the hospital overnight for observation. Physical examination and serum creatinine were within normal limits. Results of an electroencephalogram were interpretated as within normal limits. "No further incidents" occurred. The infant recovered and was discharged from the hospital on 09/06/01. The diagnosis at discharge was "postvaccination seizure" FOLLOW UP Information: The most recent information was received on 10/22/01 the vaccine provider stated that the infant will receive no further injections of acellular pertussis vaccine. The vaccine provider considered the postvaccination seizure to be mild in intensity and possibly related either to Infanrix administration , the other vaccines administered , or to prematurity.
Age: 0.19
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Somnolence, Staring, Tongue discolouration
Clinical narrative: This report describes a seizure in a 2 month old male who received an injection of Infanrix. On 09/04/2001, the infant received his first injection of Infanrix. On that date, he also received injection of Comvax, IPOL and Prevnar. On 09/05/01, approximately 27 hours post-immunization, the infant woke from his nap crying. His mother observed that he arched his back, thrust his head back and turned red. His tongue was blue and he was foaming at the mouth. The mother also described the infant as having a momentary blank stares. All these events lasted approximately five minutes after the infant woke from his nap. She stated that the baby appeared "OK" at the time but was a little bit out of it". She immediately brought the baby to the doctor's office. By 15;30, the baby appeared to be sleepy, but the mother noted that this was a usual "sleepy time" for the baby. The doctor admitted the baby to the hospital overnight for observation. Physical examination and serum creatinine were within normal limits. Results of an electroencephalogram were interpretated as within normal limits. "No further incidents" occurred. The infant recovered and was discharged from the hospital on 09/06/01. The diagnosis at discharge was "postvaccination seizure" FOLLOW UP Information: The most recent information was received on 10/22/01 the vaccine provider stated that the infant will receive no further injections of acellular pertussis vaccine. The vaccine provider considered the postvaccination seizure to be mild in intensity and possibly related either to Infanrix administration , the other vaccines administered , or to prematurity.
Age: 0.19
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Crying, Flushing, Opisthotonus, Staring, Tongue discolouration
Clinical narrative: This report describes a seizure in a 2 month old male who received an injection of Infanrix. On 09/04/2001, the infant received his first injection of Infanrix. On that date, he also received injection of Comvax, IPOL and Prevnar. On 09/05/01, approximately 27 hours post-immunization, the infant woke from his nap crying. His mother observed that he arched his back, thrust his head back and turned red. His tongue was blue and he was foaming at the mouth. The mother also described the infant as having a momentary blank stares. All these events lasted approximately five minutes after the infant woke from his nap. She stated that the baby appeared "OK" at the time but was a little bit out of it". She immediately brought the baby to the doctor's office. By 15;30, the baby appeared to be sleepy, but the mother noted that this was a usual "sleepy time" for the baby. The doctor admitted the baby to the hospital overnight for observation. Physical examination and serum creatinine were within normal limits. Results of an electroencephalogram were interpretated as within normal limits. "No further incidents" occurred. The infant recovered and was discharged from the hospital on 09/06/01. The diagnosis at discharge was "postvaccination seizure" FOLLOW UP Information: The most recent information was received on 10/22/01 the vaccine provider stated that the infant will receive no further injections of acellular pertussis vaccine. The vaccine provider considered the postvaccination seizure to be mild in intensity and possibly related either to Infanrix administration , the other vaccines administered , or to prematurity.
Age: 36.0
Sex: M
Vaccine: YF
Symptoms: CSF test abnormal, Encephalitis, Nervous system disorder
Clinical narrative: It was reported that a 36 year old male pt was vaccinated with Yellow Fever on 09/17/2001. On 09/30/2001, the pt developed Encephalitis. Specific IgM directed against YF in the CSF which may suggest CNS infection with 17D.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erysipelas, Injection site erythema, Injection site oedema
Clinical narrative: Report 2001025790-1 describes injection site swelling in a 4 year old male who received Infanrix. The vaccinee provider submitted this report directly to VAERS. Medical history, concurrent conditions, and concurrent medications were not specifed. On 10/19/2001, the vaccinee received his fifth 0.5mL injection of Infanrix and an injection of IPV vaccine, in his left arm. Additionally, he received an injection of MMR vaccine; site unspecified. Within 24 hrs, on 10/20/2001, the vaccinee returned to his physician with redness and swelling at the site of injection on the left arm. The physician prescribed Augmentin. Two to three days later, the erythema had resolved. As of 10/25/2001, the adverse events had resolved.
Age: 0.3
Sex: M
Vaccine: DTAP, HEP
Symptoms: Crying, Loss of consciousness, Rash, Skin discolouration, Somnolence
Clinical narrative: On 11/15/01, the vaccinee received his second injections of Infanrix and Engerix-B. Within five minutes post-immunization, the infant began crying, turned blue, experienced a decrease in oxygen saturation to 96%, 'appeared to either fall asleep or pass out" and developed a rash on the face and body. The infant was observed in the physician's office for two hours. The rash lasted 1.5 hrs. The other events had also resolved and the infant was sent home. The reporting physician considered the events to be possibly related to Infanrix and Engerix-B administration. The most recent information received on 02/15/02, indicated them vaccines received another injection of Infanrix on 02/05/02 and he did not experience an adverse event.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Hypernatraemia, Pyrexia
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Eye disorder, Hypernatraemia, Hypoglycaemia
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Laboratory test abnormal, Pyrexia, White blood cell count increased
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hypoglycaemia, Laboratory test abnormal
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia, White blood cell count increased
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hyperventilation, Hypoglycaemia
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hyponatraemia, Ketosis, Laboratory test abnormal, Pyrexia, Tachycardia
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Blood urea increased, Convulsion, Diarrhoea, Hyperchloraemia, Hypernatraemia
Clinical narrative: Report 20010291621 describes a seizure in a 4 month old female who received an injection of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed. Additional information was received from manufacturer, who received it from an agency. This report has also been forwarded to a medical institution. There were no pre-existing conditions, illnesses at the time of immunization, or concurrent medications. The infant had no adverse experiences following receipt of prior immunizations and had not received any other vaccines within four weeks of 29 NOV 2001. On 29 NOV 2001, the infant received her second injection of Infanrix. On that date, she also received her second injections of 7 valent pneumococcal conjugate vaccine and combination Haemophilus influenzae type b conjugate/hepatitis B vaccine, and her first injection of inactivated poliomyelitis virus vaccine. On 30 NOV 2001, one day post-immunization, she experienced a seizure characterized by her eyes rolling back and jerking of her shoulders and chest on and off for 20 minutes. She had a fever of 105.4 degrees F. She also experienced diarrhea. She was taken to the local ER and hospitalized. White blood cell count was 21,000 cells/cu mm with 58% segmented neutrophils, 16% banded neutrophils, 18% lymphocytes, and 8% atypical lymphocytes. Another white blood cell count was 30,100 cells/cu mm. Additional analyses revealed blood bicarbonate (NOS) 17 mEq/L, serum sodium 156 mEq/L, glucose 23 mg/dL, C-reactive protein 2.6 mg/dL, blood urea nitrogen 22 mg/dL, and platelets 413,000/cu mm. Urinalysis was normal and blood cultures were negative. The infant was treated with ibuprofen (Motrin), paracetamol (Tylenol), lorazepam, phenytoin, and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severeity and possibly related to Infanrix administration. The Infanrix immunization series was discontinued. This is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccines. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however, this is not a valid lot number.